Dr. Petros Kechagioglou

PostDoc

Petros obtained his BSc in Chemistry and MSc in Biochemistry at the Aristotle University of Thessaloniki, Greece. During his PhD, he focused on the possible association between the progress of breast cancer and the role of proteins involved in the PI3K/Akt pathway. Following his PhD studies, he worked as a postdoctoral researcher at the University of Saskatchewan, Canada. His research activity was to study the effects of the antacid proton pump inhibitors on tumor progression and metastatic dissemination in oral cancer.

In 2021, he became a member of the Research Group of Prof. Dr. Krishnaraj Rajalingam. His research objective is to evaluate the efficacy of kinase inhibitors in breast cancer, and to consolidate their mechanism of action by identifying other targets engaged by those compounds.

Prefessional Experience

• 2021 - present: Postdoctoral Researcher, Research Group of Prof. Dr. Krishnaraj Rajalingam, CBU, JGU Mainz, Germany

• 2017 - 2019: Postdoctoral Researcher, Department of Surgery, University of Saskatchewan, Canada

• 2016 - 2017: Research Fellow, Department of Chemistry, Aristotle University of Thessaloniki, Greece

Education

• 2011 - 2014: PhD candidate in Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, Greece

• 2009 - 2011: Master of Science in Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, Greece

• 2004 - 2009: Bachelor of Science in Chemistry, Department of Chemistry, Aristotle University of Thessaloniki, Greece

Publications

• Riegel, K., P. Vijayarangakannan, P. Kechagioglou, K. Bogucka, and K. Rajalingam, Recent advances in targeting protein kinases and pseudokinases in cancer biology. Frontiers in Cell and Developmental Biology, 2022. 10.